Preventing Heart Disease in New York City Children and their Caregivers
July 15, 2014
Mount Sinai Heart has been awarded nearly $4 million from the American Heart Association to increase cardiovascular health in NYC children at highest risk.
Novel Nanotherapy Breakthrough May Help Reduce Recurrent Heart Attacks and Stroke
January 20, 2014
Icahn School of Medicine at Mount Sinai designs HDL nanoparticle to deliver statin medication inside inflamed blood vessels to prevent repeat heart attacks and stroke.
Researchers Investigating How to Make PET Imaging Even Sweeter
January 13, 2014
Mount Sinai Heart testing new sugar-based tracer to help in the cardiovascular imaging hunt for inflamed high-risk, vulnerable artery plaques before they rupture.
Junqian (Gordon) Xu, PhD, Awarded $150,000 Grant From Radiological Society of North American Research and Education Foundation
October 24, 2013
Grant will support development of more advanced imaging of the spinal chord.
Study Finds Tiny, Targeted Drug Particles May Be Effective in Treating Chronic Diseases
March 18, 2013
Doses of medicine 100,000 times smaller than a human hair prevent the tissue damage associated with atherosclerosis and other chronic diseases in mice.
Mount Sinai Presents Landmark Research at American College of Cardiology Meeting
March 27, 2012
New Statin Regimen, Unrecognized Heart Disease Symptoms, New Imaging Innovations Among Key Research at Leading Cardiology Conference
Jagat Narula, MD, PhD, Recognized by American College of Cardiology as "Gifted Educator"
January 19, 2012
Dr. Jagat Narula, Chair in Cardiology at The Mount Sinai Medical Center, has received the prestigious "Gifted Educator Award" for his renown as an educator in cardiology.
MultiVu - "Philips Receives CE Mark for First New Imaging Modality in 10 Years"
January 25, 2011
Versatile whole body PET/MR imaging system enables clinicians to see chronic diseases earlier and monitor efficacy of treatment.
Molecular Imaging Insight – "PET MR Birth of a New Modality"
November 1, 2010
A new imaging modality is coming into clinical focus that promises to improve the diagnosis and monitoring of brain disorders such as Alzheimer’s, and cancers such as prostate, breast and liver, and even heart disease.